V

Velocity Clinical Research | Austin, TX

Research site

(Unclaimed)

Location

12515-2 Research Boulevard Suite 225, Austin, Texas, United States of America

Site insights

Top conditions

Top treatments

Bupropion Hydrochloride

JATENZO®

Naltrexone Hydrochloride

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)

In this open-label Phase 3b, single arm trial, persistence of antibodies and long term safety will be evaluated in up to 375 participants rolled over...

Active, not recruiting

Chikungunya Virus Infection

Biological: VLA1553

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB).

Active, not recruiting

Obesity

Drug: Placebo

Drug: Naltrexone-Bupropion (NB) Combination

Trial sponsors

C

T

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms